Introduction
In the design of inhibitors acting at an enzymat ic level, one important feature is the structural re semblance between inhibitors and substrates. For example, in mitochondrial electron transport sys tem, piericidines and their analogs bearing a close structural resemblance to ubiquinone, act as po tent inhibitors [1] . In photosynthetic electron trans port system, on the other hand, the plastoquinone site is the main target of various photosynthesis inhibiting herbicides. Their mode of inhibition is a consequence of displacement of plastoquinone from its binding site on the protein subunits of pho tosystem II [2] . In view of this, we may reasonably expect that chemicals structurally resembling plas toquinone should inhibit photosynthetic electron flow at the plastoquinone binding site. In fact, dibromothymoquinone [3] and tetra-halogenated 4-hydroxypyridine [4] , both structurally analogous to plastoquinone, are known as potent inhibitors.
4-Pyrones and 4-hydroxypyridines are also known as structurally related inhibitors, but their activity level are low. It has been also reported that 4-hydroxypyridines enhance their activity upon halogenation both on the pyridine ring and a-position of the side chain at 6-position, while 4-pyrones do not [5] .
It is believed that lipophilicity of the compounds plays an important role in enhancing the PET in hibitory activity [6] [7] [8] [9] . It has further been suggest ed that the phenyl group in the lipophilic side chain may have interactions with some amino acid residues surrounding the binding site of the D 1 protein [10] . A convenient synthetic route for 4-hydroxypyridines allows us to prepare many types of compounds having various substituents on the pyridine ring and to examine the effect of halogenation, change of lipophilicity, and inser tion of phenyl group into the molecule. We report here the structure-activity relationships of halo genated 4-hydroxypyridine and the possible rea son for the activity enhancement upon halogena tion. We further analyzed comparatively the fea tures of inhibition of the Hill reaction by various compounds in atrazine-resistant and -susceptible thylakoids from Brassica napus by employing ther moluminescence measurements, and confirmed that upon halogenation, 4-hydroxypyridines change their mode of binding to the D 1 protein. It was also suggested that this change occurs in ac cordance with the change of their predominant tautomeric forms. Both change of UV-spectrum upon halogenation and chemical analysis of nonand dibromo-4-hydroxypyridines support this suggestion.
Materials and Methods

P S II inhibition in thylakoids
Spinach (Spinacia oleracea L.) thylakoids pre pared by usual methods [11] were stored in liquid nitrogen. Photosynthetic electron transport activi ty was measured at pH 7.0 in 2 ml of a medium (50 m M HEPES, 10 m M NaCl, 20 m M methylamine) containing 50 |i m DCIP (2,6-dichlorophenolindophenol) and 0.5 ng/ml of chlorophyll. Photoreduction of DCIP was measured spectrophotometrically at 600 nm, after dilution of the thylakoid suspension with 0.4 m sucrose, 10 m M NaCl, 5 m M MgCl2 and 40 m M tricine (pH 7.8). The PS II inhibitory activities of the compounds were expressed in terms of p/50 values, the negative logarithms of the concentration ( m ) of the com pounds for 50% inhibition of electron transport. Experiments were repeated at least three times, and the average values were reported. Thylakoids from both wild type and atrazine-resistant Brassi ca napus were isolated in the same manner and were used for in assays as described above for spin ach thylakoids.
Thermoluminescence measurement
Thylakoids were diluted (0.25 mg Chl/ml) with 25% (v/v) glycerol, 10 mg MgCl2 and 50 m M HEPES-NaOH (pH 7.0), and were illuminated with orange light for 45 sec, and then dark-adapt ed for 5 min at room temperature. Thermolumi nescence was measured as described in [12] . The dark adapted thylakoids were illuminated with xenon flashes, rapidly cooled to -196 °C, then lu minescence emission was recorded during heating at a rate of 0.8 °C/sec.
Results
Structure-activity relationships
All the compounds examined in this study are classified into two groups based on the position of the longest side chain on the pyridine ring: Type I compounds have the long side chain adjacent to the nitrogen atom, while Type II compounds have the long side chain adjacent to the 4-hydroxyl at taching carbon atom. Fig. 1 shows the effect of 3,5-dihalogenation of the pyridine ring of Type I compounds on the activity. Compounds 1 -4 have a non-brominated side chain, and none of them ex hibited the activity. However, 3,5-dibromination of their pyridine rings enhanced the activity as in dicated in Fig. 1 . This activity enhancement was observed particularly for Type I compounds that carried a phenyl ring in their side chains (5 -8 ). While 3,5-dibrominated compounds having a straight alkyl chain, but no phenyl ring did not show any marked increase in activity upon the dibromination [5] . The activity enhancement by side chain modification indicates that lipophilicity and/ or existence of phenyl ring in the side chain are the important requirement for the expression of PET inhibiting activity by such compounds as demon strated in the modification of compound 5. The ac tivity of 5 was low (p/50 = 4.4), but compounds 9, 10, 4-tt-butoxyphenyl-(12), 4-phenylphenyl-(13), 2,4-dichlorophenyl-(14), 4-phenoxyphenyl-(15) and 3,4-methylenedioxyphenyl-(16) derivatives were 10-to 100-fold more active than compound 5. Compound 17, in which the pyridine ring was substituted with iodine atoms, showed the highest activity among the 3,5-dihalogeno-4-hydroxypyridines examined.
As shown in Table I , the activity of 3,5-dibromo-4-hydroxypyridines was increased by bromination of the a-position of the side chain at 6-position (5 -* 18, 12 -* ■ 23, 15 -> 24, 13 -»• 25). One exception was compound 14, bromination of which caused no distinct change in the activity (22). Di-iodinated compound 26 also showed the activity as high as DCMU. Elongation of the side chain of compound 18 clearly enhanced the activi ty (19-21). This activity enhancement is probably due to increase in lipophilicity of the side chain as has been suggested for other PET inhibitors [6] [7] [8] [9] .
In Fig. 2 , the effect of halogenation of 4-hy droxypyridines possessing a long side chain at 
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The degree of the activity enhancement is expressed in ( ). and 36, 37 -> 38). The order of effectiveness in ac tivity enhancement is iodine > bromine > chlorine.
Side chain elongation at 3-position enhanced the activity, probably due to the increase in lipophilici ty. Insertion of a phenyl group into the long side chain was appreciably more effective (38) as com pared with the effect on the compounds possessing an alkyl straight chain. We note that these Type II compounds are totally different from Type I com pounds in the structural requirement for expres sion of the activity: Type I compounds require 3,5-dihalogens of the pyridine ring for activity ex pression whereas Type II compounds require only 5-halogen of the pyridine ring. When the 3-halogen of Type I compounds was substituted with a methyl group, inhibitory activity was drastically lost, as demonstrated by compounds 33 and 3-bromo-2-decyl-4-hydroxy-5,6-dimethylpyridine [5] : the structural difference between the two com pounds is only the positions of the methyl and A?-decyl groups, however their activity is greatly different by a factor of about 1000. 3-Alkoxy-4-hydroxypyridines of Type II ac quired higher activity by bromination at the 5-position, and side chain elongation was also effective for activity enhancement. This result sug gests that for Type II compounds the lipophilicity of the 3-position is the most important factor while the methyl group at 6-position plays no role in the activity expression.
Mode o f action
The mode of action of non-halogenated 4-hydroxypyridines has already been investigated, and they are known to act as plastoquinone-pool inhibitors [15] . PET inhibitory activity of 4-hy droxypyridines was enhanced by halogenation re gardless of the position of the long side chain. This led us to assume that the mode of action of 4-hydroxypyridines may be altered upon halogenation. Table II lists the peak temperatures of thermo luminescence glow curves of spinach thylakoids in the presence of various inhibitors. From the peak temperature of thermoluminescence Q-band, the orthodox inhibitors are known to be classified into three groups: upon treatment with ureas, triazines and phenols the thermoluminescence B-band is converted to the Q-band due to interruption of electron transport from QA to QB, and the peak position of the resulted Q-band is located at differ ent temperatures corresponding to the types of the inhibitors, +8, -2 , and -9 C with DCMU, atra zine and ioxynil, respectively [13] . Notably, the glow peak of the thylakoids treated with nonbrominated 4-hydroxypyridines was found at around +25 °C, an intermediate peak temperature between the B-band (control) and the DCMU-induced Q-band. These compounds are the excep tions among 4-hydroxypyridines, exhibiting the emission peak at such a high temperature as re ported for AP series compounds [14] . This suggests that the mode of action of non-brominated 4-hydroxypyridines differs from that of other in hibitors, in good accordance with the results of our previous study [15] , Type I-4-hydroxypyridines (21 and 24) exhibited the glow peak at -9 and -6 °C, respectively, suggesting that compounds 21 and 24 are classified as phenol-type inhibitors. On the other hand, Type II-4-hydroxypyridines (35 and 36) exhibited the glow peak at +3 and +4 °C, re spectively, suggesting that these two compounds are rather classified as urea-atrazine type inhibi tors than phenol-type inhibitors. Atrazine-resistant weeds provide another infor mation about the mode of binding of various PET inhibitors. By comparing the R/S ratio [ratio of I50 (resistant type) divided by ^50 (susceptible type)] of various compounds, we can classify them into sev eral groups [16] [17] [18] . Generally, a mutation giving rise to atrazine-resistance results in an increased sensitivity to phenol-type herbicides to exhibit an R/S value lower than one, whereas the inhibitory activity of urea-type remains mostly unchanged showing an R/S value nearly the same or slightly higher. In Table III type inhibitors. As a consequence of this classifica tion, we infer that 4-hydroxypyridines change their mode of action upon halogenation.
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Discussion
Trebst et al. [19] were the first to report tetrahalogenated-4-hydroxypyridines as PET inhibi tors. They classified them as phenol-type inhibi tors based on their analyses of their mode of action advocating same essential features of this type of inhibitors. The structural difference between their derivatives and ours is the existence of lipophilic side chains on the heteroring. Comparison of these two sets of results led us to conclude that 4-hydroxypyridines change their mode of action upon halogenation, and this change gives rise to the activity enhancement. Generally, when the hy droxyl group of phenol-type inhibitors is methyl ated by diazomethane treatment, they cannot act any more as a phenol, and lose the inhibitory ac tivity. The O-methylated bromo-4-hydroxypyridines also lose their high inhibitory activity upon methylation and act merely as plastoquinone-pool inhibitors. The idea of change in mode of action is supported by the change in the UV-absorption spectrum and color reaction by FeCl3 spray (FeCl3 is a good spray reagent for identifying the phenol hydroxyl group). When the hydroxyl group of non-brominated 4-hydroxypyridines is methylated by diazomethane treatment, a large change in UV absorption spectrum takes place. This is probably because the heteroring of non-brominated com pounds is in tautomeric equilibrium with preferen-tial population of keto-form (45), but upon meth ylation the equilibrium reverses toward enol-form (46) to lock all the molecules in the pyridine form, the requirement for phenol-type inhibitors. In con trast, diazomethane treatment of dibrominated 4-hydroxypyridines did not induce any discernible change in UV-absorption spectrum. This indicates that the heteroring of these dibrominated 4-hydroxypyridines were in the enol-form both before and after methylation. These interpretations ac count well for the fact that brominated 4-hydroxy pyridines can react with FeCl3 to undergo color reaction while non-brominated 4-hydroxypyridines do not, and also explain well the observation in this study that the PET inhibitory activity of 4-hydroxypyridines was markedly enhanced by bromination: unless brominated, the compounds could not act as phenol-type inhibitors due to the preferential keto-form structure of their nonbrominated heteroring.
If there are other candidates for new PET inhib itor possessing a heteroring carrying a hydroxyl group in their molecules, halogenation of the het eroring and/or the substituent(s) may yield fruitful results. For the mode of binding of a phenol-type inhibitor to D 1 protein, there remain many black boxes to be investigated, we will be able to utilize those type of compounds for the study of inhibitor-protein binding.
